SPHK1 and Anxiety: A previous study has reported that Kpna1 KO mice show decreased anxiety-like behavior (in EPM and OFT), which was attenuated by either administration of a Sphk1 inhibitor PF-543, or rescue of Kpna1 in the ventral hippocampus [15].